BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27940340)

  • 21. The effect of 7,8,4´-trihydroxyflavone on tyrosinase activity and conformation: Spectroscopy and docking studies.
    Shang C; Zhang Y; You X; Guo N; Wang Y; Fan Y; Liu W
    Luminescence; 2018 Jun; 33(4):681-691. PubMed ID: 29479807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and computational docking studies on the inhibition of tyrosinase induced by oxymatrine.
    Liu XX; Sun SQ; Wang YJ; Xu W; Wang YF; Park D; Zhou HM; Han HY
    Appl Biochem Biotechnol; 2013 Jan; 169(1):145-58. PubMed ID: 23160948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory kinetics of chlorocinnamic acids on mushroom tyrosinase.
    Hu YH; Liu X; Jia YL; Guo YJ; Wang Q; Chen QX
    J Biosci Bioeng; 2014 Feb; 117(2):142-146. PubMed ID: 23958639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular inhibitory mechanism of dihydromyricetin on mushroom tyrosinase.
    Chen J; Liu S; Huang Z; Huang W; Li Q; Ye Y
    J Biomol Struct Dyn; 2018 Nov; 36(14):3740-3752. PubMed ID: 29067862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the inhibitory activity and mechanism differences between norartocarpetin and luteolin for tyrosinase: A combinatory kinetic study and computational simulation analysis.
    Zhang L; Zhao X; Tao GJ; Chen J; Zheng ZP
    Food Chem; 2017 May; 223():40-48. PubMed ID: 28069121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico approach to inhibition of tyrosinase by ascorbic acid using molecular docking simulations.
    Senol FS; Khan MT; Orhan G; Gurkas E; Orhan IE; Oztekin NS; Ak F
    Curr Top Med Chem; 2014; 14(12):1469-72. PubMed ID: 24917394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
    Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
    Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the combined effect and inhibition mechanism of 4-hydroxycinnamic acid and ferulic acid as tyrosinase inhibitors.
    Yu Q; Fan L
    Food Chem; 2021 Aug; 352():129369. PubMed ID: 33706137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Computational Simulation Integrating Inhibition Kinetics for Detecting Tyrosinase Inhibitor: Salsalate Is a New Inhibitor.
    Xu JH; Lee J; Wang W; Park YD
    Protein Pept Lett; 2022; 29(9):744-759. PubMed ID: 35929627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Docking, Synthesis, and Tyrosinase Inhibition Activity of Acetophenone Amide: Potential Inhibitor of Melanogenesis.
    Nazir Y; Rafique H; Roshan S; Shamas S; Ashraf Z; Rafiq M; Tahir T; Qureshi ZU; Aslam A; Asad MHHB
    Biomed Res Int; 2022; 2022():1040693. PubMed ID: 35059457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inhibition mechanism of dihydromyricetin on tyrosinase and the joint effects of vitamins B
    Fan M; Zhang G; Pan J; Gong D
    Food Funct; 2017 Jul; 8(7):2601-2610. PubMed ID: 28686246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiro-acridine inhibiting tyrosinase enzyme: Kinetic, protein-ligand interaction and molecular docking studies.
    Menezes TM; de Almeida SMV; de Moura RO; Seabra G; de Lima MDCA; Neves JL
    Int J Biol Macromol; 2019 Feb; 122():289-297. PubMed ID: 30401647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosinase inhibitory effects of Vinca major and its secondary metabolites: Enzyme kinetics and in silico inhibition model of the metabolites validated by pharmacophore modelling.
    Sari S; Barut B; Özel A; Şöhretoğlu D
    Bioorg Chem; 2019 Nov; 92():103259. PubMed ID: 31518762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of isorhamnetin on tyrosinase: inhibition kinetics and computational simulation.
    Si YX; Wang ZJ; Park D; Jeong HO; Ye S; Chung HY; Yang JM; Yin SJ; Qian GY
    Biosci Biotechnol Biochem; 2012; 76(6):1091-7. PubMed ID: 22790928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-specific binding sites help to explain mixed inhibition in mushroom tyrosinase activities.
    Hassani S; Haghbeen K; Fazli M
    Eur J Med Chem; 2016 Oct; 122():138-148. PubMed ID: 27344491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic and computational molecular docking simulation study of novel kojic acid derivatives as anti-tyrosinase and antioxidant agents.
    Chen YM; Li C; Zhang WJ; Shi Y; Wen ZJ; Chen QX; Wang Q
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):990-998. PubMed ID: 31072148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Heptapeptide with Tyrosinase Inhibitory Activity Identified from a Phage Display Library.
    Nie H; Liu L; Yang H; Guo H; Liu X; Tan Y; Wang W; Quan J; Zhu L
    Appl Biochem Biotechnol; 2017 Jan; 181(1):219-232. PubMed ID: 27639393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phloretin as both a substrate and inhibitor of tyrosinase: Inhibitory activity and mechanism.
    Chen J; Li Q; Ye Y; Huang Z; Ruan Z; Jin N
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 226():117642. PubMed ID: 31614273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetazolamide Inhibits the Level of Tyrosinase and Melanin: An Enzyme Kinetic, In Vitro, In Vivo, and In Silico Studies.
    Abbas Q; Raza H; Hassan M; Phull AR; Kim SJ; Seo SY
    Chem Biodivers; 2017 Sep; 14(9):. PubMed ID: 28557244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiosemicarbazones as inhibitors of tyrosinase enzyme.
    Soares MA; Almeida MA; Marins-Goulart C; Chaves OA; Echevarria A; de Oliveira MCC
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3546-3550. PubMed ID: 28583798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.